Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome

Clinical Endocrinology
Byambaa EnkhmaaLars Berglund

Abstract

Levels of lipoprotein(a), Lp(a), an independent risk factor for cardiovascular disease (CVD), are affected by sex hormones. Women with polycystic ovary syndrome (PCOS) have elevated androgen levels and are at increased CVD risk. We investigated the impact of PCOS-related hormonal imbalance on Lp(a) levels in relation to apo(a) gene size polymorphism, a major regulator of Lp(a) level. Cross-sectional. Forty-one Caucasian women with PCOS based on the NIH criteria. (1) Apo(a) gene size polymorphism measured as Kringle (K) 4 repeat number; (2) total plasma Lp(a) level; (3) allele-specific apo(a) level assessing the amount of Lp(a) carried by an individual apo(a) allele/isoform; and (4) sex hormone levels. The mean age was 32 ± 6 years, and the mean BMI was 35 ± 8 with 66% of women classified as obese (BMI >30 kg/m2 ). LDL cholesterol was borderline high (3·37 mmol/l), and HDL cholesterol was low (1·06 mmol/l). The distribution of Lp(a) level was skewed towards lower levels with a median level of 22·1 nmol/l (IQR: 6·2-66·5 nmol/l). Lp(a) levels were not correlated with age, body weight or BMI. The median allele-specific apo(a) level was 10·6 nmol/l (IQR: 3·1-31·2 nmol/l), and the median apo(a) size was 27 (IQR: 23-30) K4 repeats. Al...Continue Reading

References

Jul 1, 1993·Human Molecular Genetics·C LacknerH H Hobbs
Jul 1, 1996·The Journal of Clinical Endocrinology and Metabolism·L BerglundP Henriksson
Jul 11, 2000·Molecular and Cellular Biochemistry·T DembinskiP C Choy
Dec 16, 2000·Arteriosclerosis, Thrombosis, and Vascular Biology·F PaultreL Berglund
Feb 19, 2005·Diabetic Medicine : a Journal of the British Diabetic Association·A I AdlerR R Holman
Jul 16, 2005·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Murat YilmazHatice Paşaoğlu
Sep 19, 2006·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·M UshiodaD Aoki
Feb 7, 2008·The Journal of Clinical Endocrinology and Metabolism·Erdembileg AnuuradLars Berglund
Jul 5, 2008·Journal of the American College of Cardiology·Jacqueline Suk DanikPaul M Ridker
Jan 8, 2009·International Journal of Clinical Practice·K BerneisE Carmina
Jun 11, 2009·JAMA : the Journal of the American Medical Association·Pia R KamstrupBørge G Nordestgaard
Jul 23, 2009·JAMA : the Journal of the American Medical Association·UNKNOWN Emerging Risk Factors CollaborationJohn Danesh
May 8, 2010·Journal of the American College of Cardiology·Sebhat ErqouJohn Danesh
Oct 23, 2010·European Heart Journal·Børge G NordestgaardUNKNOWN European Atherosclerosis Society Consensus Panel
Jun 2, 2011·Human Reproduction Update·Konstantinos A ToulisBasil C Tarlatzis
Jul 16, 2011·Translational Research : the Journal of Laboratory and Clinical Medicine·Byambaa EnkhmaaLars Berglund
Sep 25, 2012·Journal of Internal Medicine·F Kronenberg, G Utermann
Oct 24, 2012·Breast Cancer Research and Treatment·Kishor M WasanJames N Ingle
Dec 4, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Byambaa EnkhmaaLars Berglund
Oct 29, 2013·Journal of the American College of Cardiology·Pia R KamstrupBørge G Nordestgaard

❮ Previous
Next ❯

Citations

Sep 21, 2020·The Journal of Clinical Endocrinology and Metabolism·Connie B NewmanLisa R Tannock

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.